Cargando...
Trends in anemia management in hemodialysis patients with cancer
BACKGROUND: Erythropoiesis-stimulating agents (ESAs), intravenous iron, and blood transfusion are used to treat anemia in both end-stage renal disease (ESRD) and cancer. However, anemia treatment patterns have not been described among ESRD patients undergoing hemodialysis with concurrent cancer, esp...
Guardado en:
| Publicado en: | Am J Nephrol |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4618160/ https://ncbi.nlm.nih.gov/pubmed/26439712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000440771 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|